Problems and perspectives of application of beta-interferons and copaxon in the treatment of multiple sclerosis

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 99, Issue 4, 1999, Pages 33-36

  Gusev, E I ^a   Boiko, A N ^a   Pozer, Ch ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; IMMUNOLOGICAL ADJUVANT; PEPTIDE;

HUMAN; MULTIPLE SCLEROSIS; REVIEW;

ADJUVANTS, IMMUNOLOGIC; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; PEPTIDES;

EID: 0032609835     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Comi G., Martineli V., Martino G. Eur J Neurol 1998; 5: 2: 19-21.
2. Ebers G.C., Rice G.P.A., Oger J. et al. CXXII annual Meeting of the American Neurological Association (28.09-1.10.97).
3. Fazekas F., Deisenhammer F., Strasser-Fuchs S. et al. Lancet 1997; 349: 589-593.
4. Freedman M.S. Presented at 123rd Annual Meeting of the American Neurological Association (18-21.10.98). Monreal, Canada.
5. Gusev E.I., Demina T.L., Boiko A.N., Pinegin B.V. J Neurol 1994; 241: 8: 500-510.
6. IFNB Multiple Sclerosis Study Group, University of British Columbia MS/MRI Analysis Group. Neurology 1995; 45: 1277-1285.
7. Jacobs L., Cookfair D.L., Rudick R.A. et al. Ann Neurol 1996; 39: 285-294.
8. Johnson K.P., Brooks B.R., Cohen J.A. et al. Neurology 1995; 45: 1268-1276.
9. Johnsson B., Henriksson F. Eur J Neurol 1998; 5: 2: 35-37.
10. Lea A.P., Goa K.L. Copolymer-1. Clin Immunother 1996; 6: 319-331.
11. Simon J.H., Jacobs L.D., Campion M. et al. Ann Neurol 1998; 43: 79-87.
12. Storch M., Lassmann H. Cur Opin Neurol 1997; 10: 186-192.
13. Thompson A.J., Hobart J.C. Neurol 1998; 245: 189-196.
14. Trapp B.D., Peterson J., Ransohoff R.M. et al. N Engl J Med 1998; 338: 278-285.
15. Tuohy V.K., Weinstock-Guttman B., Kinkel R.P. J Clin Invest 1997; 99: 1682-1690.
16. Ustun T.B. Eur J Neurol Sci 1998; 5: 2: 3.
17. Wingerchuk D.M., Noserwothy J.H., Weinshenker B.G. Mayo Clin Proc 1997; 72: 1070-1079.